ArticleFrontiers in oncology2023

Anlotinib combined with radiotherapy and chemotherapy for recurrent pelvic osteosarcoma treatment: a case report and literature review.

Qian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.